Structural Heart · Oct 30, 2025

Finerenone in Patients Undergoing TAVR for Nonrheumatic Aortic Stenosis: Insights From a Real-World Cohort

By Massad F, Badwan O, Rosenzveig A et al.

•First study to assess finerenone in valve replacement patients.•Finerenone linked to fewer heart failure events after valve replacement.•Long-term outcomes similar between finerenone and other MRAs.

doi.org/10.1016/j.shj.2025.100751Open accessPubMed 41675393Interventions